CompletedNot Applicable

Beat to Beat A Study in Paediatric, Adolescent and Young Adult Patients Who Are Undergoing or Have Undergone Cancer Therapy to Evaluate the Agreement Between QTc Measured Using 12 Lead Electrocardiogram (ECG) and a Wearable Device ECG

Australia45 participantsStarted 2023-02-07

Plain-language summary

A prospective study in paediatric, adolescent and young adult patients aged 7 to 18 years to evaluate the agreement between QTc measured using 12 lead electrocardiogram (ECG) and the wearable device ECG.

Who can participate

Age range7 Years – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. iPhone (6s or later) with iOS version 15.0 or later defined as iPhone model/iOS version used to complete screening eligibility.
✓. Proficient in written and spoken English, defined by self-report of comfort reading, writing, and speaking English on iPhone.
✓. Valid phone number associated with iPhone, ascertained from self-report.
✓. Valid email address, ascertained from self-report.
✓. Participants or parents need to be able to press down on the wearable device crown for 30 seconds

What they're measuring

Recording of a 12 lead ECG and wearable device ECG

Timeframe: Day 1 of inpatient stay

Recording of a 12 lead ECG and wearable device ECG

Timeframe: Day 4 of inpatient stay

Calculation of QT interval by two blinded health professionals

Timeframe: Day 1 of inpatient stay

Calculation of QT interval by two blinded health professionals

Timeframe: Day 4 of inpatient stay

Trial details

NCT IDNCT05615376

SponsorMurdoch Childrens Research Institute

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-06-30

View on ClinicalTrials.gov More Neoplasms trials